Company: HCTI
Filing Date: 2025-10-15
Form Type: DEF 14A
Source: 0001213900-25-099128
Chunk: 9

Company: Healthcare Triangle, Inc.
Filing Date: 2025-10-15
Form: DEF 14A
Chunk 9
---
, operational and capital markets experience.

Sujatha Ramesh. Ms. Ramesh has
served as our Chief Operating Officer since March 2025, and as a member of our Board since April 2025. Ms. Ramesh has a distinguished
career of over 25 years of senior executive experience in the technology and financial services industry, having previously served as
Global Head of Strategic Initiatives at Citigroup (2006–2024), where she held senior leadership roles and led operational transformation,
governance, risk management, financial optimization, and technology modernization across global markets. Prior to Citigroup, she held
leadership positions at Publicis Sapient, Infinite Computer Solutions, and Capgemini (formerly iGATE Global Solutions), managing technology
projects and digital transformation initiatives across North America, Europe, Asia, and Latin America. A recognized industry thought
leader and honored listee in Who’s Who in America, Ms. Ramesh has spoken at global forums and served as a guest speaker at academic
institutions, mentoring future leaders. Ms. Ramesh holds an MBA from NYU Leonard N. Stern School of Business and a Master of Science
(MS) in Information Systems and Applications. We believe that Ms. Ramesh is qualified to serve as a member of our Board based on her
outstanding skills and unique experience in IT industry in connection with healthcare domain.

Ronald McClurg.Mr. McClurg has
over 30 years of financial leadership experience with public and private companies. Mr. McClurg has served as Chief Financial Officer
of NeuroOne Medical Technologies Corp. (Nasdaq: NMTC) since January 2021. Prior to joining NeuroOne, from October 2003 to June 2019,
Mr. McClurg served as VP – Finance and Administration and Chief Financial Officer of Incisive Surgical, Inc., a privately-held
medical device manufacturer. Prior to 2003, Mr. McClurg served as Chief Financial Officer and Treasurer of Wavecrest Corporation, a privately-held
manufacturer of electronic test instruments for the semiconductor industry, and served as Chief Financial Officer for several publicly-held
companies, including Video Sentry Corporation, Insignia Systems, Inc. (Nasdaq: ISIG), and Orthomet, Inc. Currently, he serves on the
board of governors of Biomagnetic Sciences, LLC and serves as a director and audit committee chair for Biotricity, Inc. (Nasdaq: BTCY).
Mr